Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

DuPont signs R&D agreement

August 14, 2006 | A version of this story appeared in Volume 84, Issue 33

DuPont has entered a research agreement with Duke University spin-off Affinergy. The North Carolina-based firm develops coatings and medical devices for the orthopedic and cardiovascular markets. It will use its site-specific biological delivery technology to find coatings and materials compatible with nonmedical biomass-based products being developed by DuPont. Affinergy's technology draws on functional peptides that bind both to a biological target and to a specific surface.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.